about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
72.27
0.47
(0.65%)
252.8K
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..